Hello, your email is unverified. Please confirm for access to all your SPH accounts. RESEND
Tianjin Zhongxin Pharmaceutical Group Corp | Buy (maintained)
April 1 close: US$0.945
Target price: US$1.70 UOB Kay Hian, April 1
Tianjin Zhongxin Pharmaceutical Group's reported Q4 and full-year 2018 net profits came in at 158.7 million yuan (S...
Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
CALL +65 6388 3838 EMAIL firstname.lastname@example.org
OPERATING HOURS (+8 GMT) MON-FRI: 8:30AM-5:30PM
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
MAINBOARD-listed agri-business group Wilmar International posted a 20 per cent rise in net profit for the third...
Stories you might have missed
MAINBOARD-LISTED integrated fish service provider Qian Hu has appointed Yap Kok Cheng as its new chief executive,...
[OSLO] Norway's US$1.1 trillion sovereign wealth fund, the world's largest, is having trouble finding suitable...
[HONG KONG] Hong Kong's economy contracted 3.4 per cent in the third quarter compared with a year earlier, the...